使用共享的临床决策支持来减少药物不良事件并提高患者安全
Jiancheng Ye1, Sophie Bronstein1
1Weill Cornell Medicine, Cornell University, New York, NY, United States.
Frontiers in digital health
|December 22, 2025
概括
药物不良事件 (ADEs) 往往没有被发现. 共享临床决策支持 (SCDS) 将患者参与与技术相结合,以提高安全性和减少ADEs.
科学领域:
- 医疗保健安全 医疗保健安全
- 临床信息学 临床信息学
- 患者安全 患者安全
背景情况:
- 药物是必不可少的,但会导致不良药物事件 (ADEs),导致发病率,死亡率和成本.
- 由于依赖于自愿报告和监测不足,大多数ADE都没有被发现.
- 事实上,ADE的实际影响可能被低估了.
研究的目的:
- 调查减少ADE的共享临床决策支持 (SCDS).
- 通过将临床决策支持系统与共享决策集成来提高患者安全.
- 探索预防ADEs的策略.
主要方法:
- 进行了2025年6月为止的文献叙事综述.
- 经过验证的患者安全框架被用来确定影响ADE的因素.
- 分析了背景因素,挑战和ADE预防策略.
主要成果:
- ADE是由提供者问题,临床环境,药房系统和患者变量等因素造成的.
- 提供者疲劳,监控不足,管理错误和通信失败是关键风险.
- 成功减少ADE需要综合健康IT,利益相关者的参与和质量改进.
结论:
- 共享临床决策支持使患者在医疗保健决策中获得权力.
- 将SCDS与技术相结合,可以增强临床指导.
- 最有效的ADE消除策略结合了教育,人为因素,SCDS和协作护理.
相关概念视频
Nursing Clinical Information System
1.2K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.2K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Methods of Documentation VI: Case Management Model
837
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
837
Patient-centered Care
2.8K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.8K
Therapeutic Drug Monitoring: Overview and Classification
270
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
270


